AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update
Avita Medical, Inc. (RCEL)
Company Research
Source: Business Wire
U.S. RECELL® System product sales of A$5.81M for fiscal third quarter VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal third quarter ended 31 March 2020 (Q3) today in its Appendix 4C - Quarterly Cash Flow Report filed with the Australian Securities Exchange (ASX).U.S. Commercial Sales of RECELL® System for Quarter Ended 31 March 2020Product sales and other revenues for the third quarter and nine months ended 31 March 2020 were as follows (unaudited): Three Months EndedNine Months Ended(Thousand Australian $’s)31 March31 March 2020201920202019U.S. product salesA$5,809A$2,206A$15,083A$3,308International product sales148189558900Total product sales
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- Avita Medical (RCEL) is now covered by Northland Securities. They set an "outperform" rating and a $10.00 price target on the stock.MarketBeat
- AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
- AVITA Medical to participate at the TD Cowen 46th Annual Health Care ConferenceGlobeNewswire
- Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- Avita Medical (NASDAQ:RCEL) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.MarketBeat
RCEL
Earnings
- 11/6/25 - Miss
RCEL
Sec Filings
- 3/6/26 - Form 3
- 2/23/26 - Form 4
- 2/19/26 - Form 4
- RCEL's page on the SEC website